Turmacin standardized to bioactive polysaccharides is Natural Remedies' answer for people looking for a herbal alternative to manage joint health.
Natural Remedies Pvt Ltd, a leading phyto-pharmaceutical company which is dedicated to delivering science backed products that deliver results, announced yet another publication on its leading brand Turmacin®. The study is titled “Safety evaluation of turmeric polysaccharide extract: Assessment of mutagenicity and acute oral toxicity”, the study has been published in the November (Volume 2013, Article ID 158348) issue of BioMed Research International, a peer-reviewed international journal in life sciences.
This study focused on characterization of toxicological properties of Turmacin using standard mutagenicity, clastogenicity and acute oral toxicity tests. Turmacin did not show any toxic effects to Wistar rats when tested at the maximum testable dose of 5 grams/kg body weight. This safety study along with the preclinical and clinical scientific evidence makes Turmacin a preferred ingredient for joint health.
“Turmacin standardized to bio active polysaccharides is our answer to those who are looking for a herbal alternative for joint health management,” said Dr. Deepak Mundkinajeddu, head of research and development at Natural Remedies. He also thanked his fellow research colleagues for developing this wonderful product. He also stated that “Turmacin being a water extract of Turmeric, did not have any safety concerns, however the present study re-enforces the point”.
Friendly and dedicated team of Natural Remedies looks forward to extend their valuable support to formulators interested in Turmacin. For enquiries, please contact firstname.lastname@example.org or visit turmacin.com.